Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Xeris Biopharma Holdings, Inc. - Common Stock
(NQ:
XERS
)
9.785
+0.705 (+7.76%)
Delayed Quote
Updated: 11:28 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xeris Biopharma Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Xeris Expects to Exceed Full-Year 2024 Financial Guidance
January 10, 2025
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 06, 2025
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference
November 26, 2024
From
Xeris Biopharma
Via
Business Wire
Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
November 11, 2024
Via
Benzinga
Earnings Outlook For Xeris Biopharma Holdings
↗
November 07, 2024
Via
Benzinga
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
May 06, 2024
Via
ACCESSWIRE
Xeris Biopharma Reports Third Quarter 2024 Financial Results
November 08, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024
October 31, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 04, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris to Participate in Upcoming Investor Conferences
August 22, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
↗
August 14, 2024
Via
Benzinga
Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying
↗
August 13, 2024
Via
Benzinga
XERS Stock Earnings: Xeris Biopharma Holdings Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
XERS stock results show that Xeris Biopharma Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Xeris Biopharma Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024
July 25, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma Announces CEO Succession Plan
July 08, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
July 03, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024
June 03, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 30, 2024
Via
Benzinga
Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)
May 30, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Socket Mobile And 3 Other Stocks Under $3 Insiders Are Buying
↗
May 13, 2024
Via
Benzinga
XERS Stock Earnings: Xeris Biopharma Holdings Misses EPS, Misses Revenue for Q1 2024
↗
May 09, 2024
XERS stock results show that Xeris Biopharma Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
May 09, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Why Are Xeris Biopharma Shares Moving Monday?
↗
May 06, 2024
Xeris Biopharma shares are up Monday after the company announced an exclusive worldwide collaboration and license agreement with Beta Bionics. Xeris said it will work with Beta Bionics to develop and...
Via
Benzinga
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics
May 06, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
May 02, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 03, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
XERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023
↗
March 06, 2024
XERS stock results show that Xeris Biopharma Holdings met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
